News - AstraZeneca, evacetrapib, Pharmaceutical

Filter

US genericization of clopidogrel will initially contract ACS market, before uptake of novel oral agents lifts sector to $2.7 billion

27-08-2012

The 12-month post-hospital acute coronary syndrome market will initially contract from just under $2…

anacetrapibAstraZenecaBrilintaBriliqueBristol-Myers SquibbCardio-vascularEli LillyevacetrapibGeneralMarkets & MarketingMerck & CoPharmaceuticalPlavixSanofi

Back to top